1. Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance). Issue 19 (7th June 2019) Authors: Blum, Kristie A.; Polley, Mei‐Yin; Jung, Sin‐Ho; Dockter, Travis J.; Anderson, Sarah; Hsi, Eric D.; Wagner‐Johnston, Nina; Christian, Beth; Atkins, Jim; Cheson, Bruce D.; Leonard, John P.; Bartlett, Nancy L. Journal: Cancer Issue: Volume 125:Issue 19(2019) Page Start: 3378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗